Isolation of Pharmaceutical-Degrading Bacteria from Lake Sediments Associated with Wastewater Effluents by Gallagher, Noreen Anne
Rochester Institute of Technology
RIT Scholar Works
Theses Thesis/Dissertation Collections
12-15-2016
Isolation of Pharmaceutical-Degrading Bacteria
from Lake Sediments Associated with Wastewater
Effluents
Noreen Anne Gallagher
ng5776@rit.edu
Follow this and additional works at: http://scholarworks.rit.edu/theses
This Thesis is brought to you for free and open access by the Thesis/Dissertation Collections at RIT Scholar Works. It has been accepted for inclusion
in Theses by an authorized administrator of RIT Scholar Works. For more information, please contact ritscholarworks@rit.edu.
Recommended Citation
Gallagher, Noreen Anne, "Isolation of Pharmaceutical-Degrading Bacteria from Lake Sediments Associated with Wastewater Effluents"
(2016). Thesis. Rochester Institute of Technology. Accessed from
  
 
 
 
 
 
 
 
 
Isolation of Pharmaceutical-Degrading Bacteria from Lake Sediments Associated with 
Wastewater Effluents 
 
 
 
by: 
 
 
 
 Noreen Anne Gallagher 
B.S., SUNY Geneseo, 2014 
 
 
 
A thesis submitted in partial fulfillment of  
the requirements for the degree of  
Master of Science in Environmental Science    
 
 
 
Thomas H. Gosnell School for Life Sciences 
College of Science 
 
 
 
Rochester Institute of Technology 
Rochester, NY 
December 15, 2016 
 
 
 
 
 
 
 
 
 
 Committee Approval:     
 
 
 ____________________________________________________________________________  
Jeffrey Lodge, Ph.D.,          Date 
Thesis Advisor 
   
 
_____________________________________________________________________________    
Anna Christina Tyler, Ph.D.,         Date 
Committee Member   
 
 
_____________________________________________________________________________ 
Corey Ptak, Ph.D.,          Date 
Committee Member 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
i 
Table of Contents  
 
Acknowledgements..................................................................................................................... iii 
 
List of Tables................................................................................................................................ iv 
 Tables................................................................................................................................. iv 
 Supplemental Tables.......................................................................................................... iv 
 
List of Figures................................................................................................................................ v 
 Figures................................................................................................................................ v 
 Supplemental Figures......................................................................................................... v 
 
Abstract......................................................................................................................................... vi 
 
Introduction................................................................................................................................... 1 
 Presence of Emerging Contaminants in Aquatic Environments......................................... 2 
 Sources of Emerging Contaminants.................................................................................... 3 
 Consequences to Aquatic Organisms.................................................................................. 4 
 Concern for Public Health.................................................................................................. 5 
 Elimination of Emerging Contaminants............................................................................. 5 
 Purpose of Study................................................................................................................. 6 
 
Methods.......................................................................................................................................... 7 
 Overview............................................................................................................................. 7 
Site Descriptions................................................................................................................. 7 
 Sampling............................................................................................................................. 9 
 Enrichment Technique........................................................................................................ 9 
 Growth of Isolates on Pharmaceutical Sources................................................................ 10 
Growth Analysis................................................................................................................ 11 
Biodegradation of Pharmaceuticals as Measured by Carbon Dioxide............................ 11 
 Biodegradation Analysis................................................................................................... 12 
 Statistical Analysis............................................................................................................ 13 
 
Results.......................................................................................................................................... 14 
 Cell Enrichment................................................................................................................ 14 
 Growth and Biodegradation of Acetaminophen by Initial Isolates.................................. 14 
 Growth and Biodegradation of Acetaminophen by Alternative Isolates.......................... 15 
 Growth and Biodegradation of Ibuprofen by Initial Isolates........................................... 15 
 Growth and Biodegradation of Ibuprofen by Alternative Isolates................................... 16 
 Growth and Biodegradation of Naproxen by Initial Isolates........................................... 17 
 Growth and Biodegradation of Naproxen by Alternative Isolates................................... 17 
 Growth and Biodegradation of 17β-estradiol by Initial Isolates...................................... 18 
 Growth and Biodegradation of 17β-estradiol by Alternative Isolates.............................. 18 
 Growth of High Capacity Isolates in Natural Water........................................................ 19  
Biodegradation of Pharmaceuticals by High Capacity Isolates in Natural  
Water................................................................................................................................. 19 
ii 
 
Discussion.................................................................................................................................... 21 
Enrichment of Bacteria from Natural Environments........................................................ 21 
 Growth of Isolates on Selected Pharmaceuticals............................................................. 22 
Biodegradation of Selected Pharmaceuticals Under Laboratory 
Conditions......................................................................................................................... 22 
 Biodegradation of Selected Pharmaceuticals Under More Realistic 
 Conditions......................................................................................................................... 23 
 Characteristics of Promising Isolates............................................................................... 25 
 
Conclusions.................................................................................................................................. 27 
 
References.................................................................................................................................... 28 
 
Tables........................................................................................................................................... 34 
 
Figures.......................................................................................................................................... 50 
 
Appendix...................................................................................................................................... 61 
 Supplemental Tables......................................................................................................... 61 
 Supplemental Figures....................................................................................................... 65 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
Acknowledgements 
 
First and foremost, I would like to express my sincere gratitude to my advisor, Dr. Jeffrey 
Lodge, for his continuous support of my thesis research. His patience, motivation, and immense 
knowledge of the topic helped me throughout this entire process. The mentoring he provided has 
improved my knowledge, confidence, and passion for the environmental sciences. I could not 
have imagined a better advisor and mentor. I would also like to thank my thesis committee, Dr. 
Christina Tyler and Dr. Corey Ptak, for all the time, consideration, and cooperation they put into 
this project. Their feedback, participation, and encouragement generally enhanced my experience 
at RIT. I would also like to thank the Student-Faculty Research Committee for funding part of 
my project. 
Finally, thank you to my mom and dad, for providing me with encouragement and 
support in not only my thesis work, but in everything I do. Last but not least, thank you to my 
brothers and sister for the continuous support and love. I could not have done this without you 
all. I would like to dedicate this work to my late best friend Brendan Englert (1992-2013). I 
know you were with me throughout this entire journey. Shine on my friend.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
List of Tables 
 
Tables 
 
Table 1. Growth of isolates on acetaminophen............................................................................. 34 
 
Table 2. Biodegradation of acetaminophen by isolates................................................................ 36 
 
Table 3. Growth of isolates on ibuprofen..................................................................................... 37 
 
Table 4. Biodegradation of ibuprofen by isolates......................................................................... 39 
 
Table 5. Growth of isolates on naproxen...................................................................................... 40 
 
Table 6. Biodegradation of naproxen by isolates.......................................................................... 42 
 
Table 7. Growth of isolates on 17β-estradiol................................................................................ 43 
 
Table 8. Biodegradation of 17β-estradiol by isolates................................................................... 44 
 
Table 9. Growth of high capacity isolates on contaminants in natural  
water sources................................................................................................................................. 45 
 
Table 10. One-way ANOVA comparing the biodegradation of pharmaceuticals  
by isolates in natural water........................................................................................................... 48 
 
Table 11. Characteristics of cultured isolates............................................................................... 49 
  
Supplemental Tables 
 
Table S-1 (a-b). Monthly precipitation rates for the Rochester and Syracuse regions................. 61 
 
Table S-2. Temperature, pH, phosphate, and nitrate measurements of surface water 
samples.......................................................................................................................................... 62 
 
Table S-3 (a-b). Average CFU/mL and ANOVA analysis for each sampling 
site................................................................................................................................................. 63 
 
Table S-4 (a-b). Average diversity of colonies and ANOVA analysis for each 
sampling site................................................................................................................................. 64 
 
 
v 
 
List of Figures 
 
Figures 
 
Figure 1 (a-d). Structures of ibuprofen, naproxen, acetaminophen, and 17β-estradiol................ 50 
 
Figure 2. Onondaga Lake sampling site....................................................................................... 51 
 
Figure 3 (a-d): Lake Ontario sampling sites................................................................................. 52 
 
Figure 4. Enrichment technique.................................................................................................... 54 
 
Figure 5. Biometer flask setup...................................................................................................... 55 
 
Figure 6. Growth of isolates on acetaminophen........................................................................... 56 
 
Figure 7. Control and isolates after 10 days of growth on acetaminophen................................... 56 
 
Figure 8. Degradation of acetaminophen by isolates.................................................................... 57 
 
Figure 9. N1S after 10 days of growth on acetaminophen in biometer flasks.............................. 57 
 
Figure 10. Biodegradation of contaminants by isolates in natural water 
sources........................................................................................................................................... 58 
 
Figure 11. Degradation of naproxen by L1S in Durand Beach water........................................... 59 
 
Figure 12. Gram stains of N1S and B1F........................................................................................ 60 
 
Supplemental Figures 
 
Figure S-1. Graduated water dipper.............................................................................................. 65 
 
Figure S-2 (a-c). Gram stains of various isolates.......................................................................... 66 
 
 
 
 
 
 
vi 
 
Abstract 
 
  Many wastewater treatment plants (WWTPs) are not properly equipped for the removal 
of various compounds, including non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, 
and hormones. These compounds are continually discharged into surface waters, which has 
become an emerging issue for environmental and public health. Microorganisms in the natural 
environment may play a crucial role in ecosystem self-purification processes such as 
contaminant degradation. The aim of this research was to determine if there were 
microorganisms from water and sediment samples located near wastewater effluent outfalls in 
Central and Western New York capable of degrading ibuprofen, naproxen, acetaminophen, and 
17β-estradiol, and if the degradation capability of microorganisms varied by sampling site. An 
isolation approach was developed using serial enrichment in mineral medium containing each 
individual pharmaceutical as the sole carbon source available to heterotrophs. After four weeks 
of enrichment, bacteria were isolated and the growth of each isolate on its selected 
pharmaceutical source was measured. The biodegradation of pharmaceuticals was then examined 
with the isolates that showed the most consistent growth. Results from the various enrichment 
experiments have led to the isolation of several heterotrophic bacteria capable of utilizing the 
compounds as their sole carbon sources. An isolate cultured from Payne Beach had the ability to 
remove up to 40.1% + 3.9% of acetaminophen, 23.2% + 5.7% of ibuprofen, and 18.6% + 5.3% 
of 17β-estradiol and an isolate cultured from Charlotte Beach had the ability to remove up to 
23.4% + 3.5% of ibuprofen, 32.2% + 2.5% of naproxen, and 29.1% + 1.9% of 17β-estradiol. The 
data suggests that there are endogenous heterotrophs located near wastewater outfalls that can 
degrade various pharmaceuticals, and that the degradation capability of microorganisms on 
certain compounds may be site specific. 
 
 
 
 
 
 
 
 
 
1 
Introduction 
 
Emerging contaminants are increasingly being detected at low levels in surface waters 
and have been gaining the attention of both the scientific community and the public as a result. 
Pharmaceuticals are a large portion of this new class of contaminants (Daughton, 2002), which 
originate from both human and agricultural use (Risen, 2012). Emerging contaminants are 
explicitly designed to be bioactive at low concentrations, making them distinct from 
conventional contaminants (Caracciolo et al., 2015). The bioactivity of pharmaceuticals and their 
metabolites possess potentially harmful effects to the environment and human health through the 
consumption of water and food containing pharmaceutical residues. This presents a major 
concern for public health since little is known regarding the potential interactive effects that may 
occur from a complex mixture of these compounds; therefore, both research and public action 
are required to reduce their presence in the environment (Risen, 2012). 
WWTPs are the largest contributor of emerging contaminants into our aquatic 
environment because they are not properly equipped to handle these compounds. Therefore, 
NSAIDs such as ibuprofen (Figure 1a) and naproxen (Figure 1b), analgesics such as 
acetaminophen (Figure 1c), and hormones such as 17β-estradiol (Figure 1d) are continually 
discharged into our surface waters. However, microorganisms in the natural environment may be 
able to compensate for their release as these organisms are involved in ecosystem “self-
purification” processes (Caracciolo et al., 2015). To date, there is a lack of knowledge regarding 
the biodegradation capability of microorganisms and the overall effects on ecological processes, 
emphasizing the importance of investigating further the degradative capability of 
microorganisms that are naturally occurring in surface waters and sediments (Caracciolo et al., 
2015). Therefore, the aim of my research was to determine if there were microorganisms in 
freshwater sediments associated with wastewater effluents that can degrade ibuprofen, naproxen, 
acetaminophen, and 17β-estradiol.  
 
 
 
 
 
2 
Presence of Emerging Contaminants in Aquatic Environments 
 
High quantities of pharmaceutical compounds are consumed annually across the globe. 
For example, in one study, it was determined that 345 tons of ibuprofen were consumed in 
Germany in 2001 and 35 tons of naproxen were consumed in England in 2000 (Nikolaou et al., 
2007). As pharmaceutical consumption increases, the risk of these compounds entering our water 
systems has become more concerning. Hence, numerous projects have been undertaken across 
the globe to measure the concentrations of these compounds in the environment (Risen, 2012). 
The United States Geological Survey (USGS) has led the way by sampling various waters across 
the country and giving us insight in to the widespread nature of the contamination (Barnes et al., 
2008; Focazio et al., 2008; Kolpin et al., 2002). For example, a 1999 and 2000 study 
implemented by the USGS found some presence of pharmaceuticals in 80% of the waters 
sampled from a large network of streams in 30 states (Kolpin et al., 2002). Although most 
pharmaceutical compounds and/or their metabolites are found at concentrations of ng/L in 
surface waters (Kim et al., 2007), concentrations of some compounds can reach into the low 
µg/L level (Kolpin et al., 2002).  
Among the most commonly prescribed drugs in modern history, NSAIDs are the most 
frequently detected pain killers in our surface waters (Caracciolo et al., 2015). Various reports 
have detected noteworthy concentrations of both ibuprofen and naproxen in our natural waters. 
This may be due to the fact that up to 30% of ibuprofen and 40% of naproxen can pass through 
WWTPs unaltered (Carballa et al., 2007). In one study, effluent samples from Back River 
WWTP in Baltimore, Maryland contained ibuprofen and naproxen at significant concentrations 
of 250 ng/L and 380 ng/L, respectively (Yu et al., 2006). However, the detection of several other 
compounds in natural waters has varied significantly. Acetaminophen was detected in 
concentrations ranging from 14 to 1600 ng/L in surface waters nearby a WWTP (Lin et al., 
2010), whereas concentrations were found to be up to 10 μg/L in numerous waters throughout 
the U.S. (Kolpin et al., 2002). Lastly, natural and synthetic hormones are often detected in the 
ng/L range (Chimchirian et al., 2007). For example, 17β-estradiol was found to be in the range of 
1 to 50 ng/L from WWTP effluents in Britain (Desbrow et al., 1998). These reports are 
significant because they show that emerging contaminants are ubiquitous in surface waters, and 
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require direct attention to determine what effects they may be having and how to limit their 
concentrations in the environment (Risen, 2012). 
 
Sources of Emerging Contaminants 
 
WWTPs are not specifically designed to remove emerging contaminants and are the 
major source of these compounds into surface waters. Several studies have determined that the 
partial removal of emerging contaminants in WWTPs often takes days to weeks (Almeida et al., 
2013; Carballa et al., 2007; Salgado et al., 2012), and depends on the type of treatment processes 
occurring at the plant and the time of year. Removal rates tend to be highest in the summer 
months since the degradative activity of bacteria is greater at warmer temperatures (Castiglioni et 
al., 2006). However, it has been suggested that the most important factor in eliminating these 
types of contaminants is the amount of time allowed for degradation (Quintana et al., 2005; 
Radjenovic et al., 2008). To ensure the greatest removal of these contaminants, longer hydraulic 
retention times and solid retention times are essential. Several studies in particular have 
suggested that hydraulic retention times of 12 hours and solids retention times of 10 days are 
successful at removing a majority of parent compounds (Clara et al., 2005; Metcalfe et al., 2003; 
Miege et al., 2008). However, a heavy precipitation event has the potential to interrupt treatment 
processes (Risen, 2012) and cause the release of partially treated wastewater into surface waters 
(Buerge et al., 2006). For example, 7 million gallons of raw sewage were recently released into 
Onondaga Lake following 21 straight hours of rain (Coin, 2016). Therefore, in order to handle 
emerging contaminants, WWTPs need to be upgraded to manage higher flow with longer 
retention times (Risen, 2012); however, doing so would be a costly affair for each plant.  
Pharmaceuticals are transported to WWTPs via two major routes. First off, most 
pharmaceuticals that are consumed by individuals are not completely eliminated in the body and 
are excreted in feces and urine (Heberer, 2002). In one study, it was found that approximately 
58-68% of acetaminophen is excreted from the body during use (Muir et al. 1997). This is of 
concern since, after excretion, most pharmaceutical compounds are still biologically active as 
they are only slightly transformed or unchanged conjugated polar molecules (Heberer, 2002). 
Second, unused or expired drugs may be improperly disposed of by individual households, 
hospitals, and nursing homes (Heberer, 2002). These drugs may be flushed down the septic 
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system or thrown in the trash, in which they will eventually runoff into landfill leachate and be 
transported through a WWTP. Pharmaceuticals may also be released directly into surface waters 
via runoff. Wastes generated on stock-raising farms often contain pharmaceutical residues, 
which are released in runoff during precipitation events (Topp et al., 2008; Heberer., 2002). For 
example, naproxen is given to horses to treat pain, and is often found in water sources that are in 
close proximity to farms (Topp et al., 2008).  
 
Consequences to Aquatic Organisms 
 
Aquatic organisms are at risk of having continuous, multigenerational exposure to 
emerging contaminants when they are released into surface waters. Organisms may develop 
various malformations during their growth (Ragugnetti et al., 2011); however, it is important to 
note that the effects of exposure during the early stages of life may not be perceived until 
adulthood (EPA, 2016a). Although, many of these contaminants exhibit low acute toxicity; 
emerging contaminants can cause significant effects at very low levels of exposure (EPA, 
2016a). Thus far, various studies have focused primarily on the effects of ibuprofen on various 
organisms since it is frequently detected in our natural waters at significant concentrations. That 
being said, sublethal effects have been reported in the µg/L to ng/L range (Risen, 2012). For 
example, a dose dependent response was observed in Java-medaka (Oryzias latipes) during 
chronic exposure to ibuprofen concentrations of 1 to 100 µg/L, which induced a decrease in 
cyclooxygenase activity and longer days between spawning (Flippin et al., 2007). Other studies 
have also found that ng/L concentrations of ibuprofen can inhibit eicosanoid synthesis in 
Daphnia magna (Hayashi 2008) and significantly lower the levels of micronuclei frequencies in 
Nile Tilapia (Oreochromis niloticus) (Ragugnetti et al., 2011). These examples of low dose 
effects reflect carefully chosen endpoints which mirror the intended effects of ibuprofen (Risen, 
2012).  
Many emerging contaminants also act as endocrine disrupters, which alter the normal 
functions of hormones. Exposure to endocrine disrupters can lead to a variety of health effects 
for aquatic organisms, including growth and reproductive effects. In one study, the effects of 
17β-estradiol on the reproduction of Java-medaka were tested (Imai et al. 2005). After six 
months of exposure to 17β-estradiol, several key findings were reported including reduced 
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fecundity, inhibition of secondary sexual characteristics, elevated vitellogenin production, and 
feminizing effects (Imai et al. 2005). While certain species may be more sensitive than others to 
endocrine effects (Risen, 2012), there are clear risks associated with hormone release into our 
waters.  
 
Concern for Public Health 
 
Pharmaceuticals in drinking water pose significant risks to humans and ecosystem health 
as well. The reported levels of pharmaceuticals in water may be significantly lower than those 
applied during general use; however, the potential health effects associated with long term 
exposure to trace levels cannot be ignored with respect to water reuse purposes (Kümmerer et al. 
2001). There is also a lack of knowledge regarding the fate of various compounds (Murdoch et 
al., 2015) and their biotransformations in the natural environment. As stated previously, many of 
these compounds and/or their metabolites are unchanged, and thus biologically active in the 
environment (Wojcieszyńska et al., 2014). Therefore, reactions may occur in the human body 
that differ from the intended purpose of the compounds. Humans may be at risk through 
cumulative effects from long-term exposure to very low levels of the compounds since they have 
the potential to bioaccumulate in the body’s tissues (Nikolaou et al., 2007). Endocrine disruption 
is also a warranted concern as endogenous chemicals have the capability of triggering gene 
expression cascades (Casals-Casas et al., 2011). However, more research in all of these areas is 
required to develop a better understanding of what these compounds have the potential to do in 
the human body, especially long-term.  
 
Elimination of Emerging Contaminants 
 
Scientists have taken many approaches to investigating the elimination and removal of 
emerging contaminants in the natural environment. Recent studies have looked at pure strains 
tied to co-metabolism to degrade pharmaceutical compounds. In one study, a low level of 
naproxen removal accompanied by a decrease in Stenotrophomonas maltophilia KB2 was 
detected in a monoculture experiment (Wojcieszyńska, et al., 2014). However, when glucose and 
phenol were added individually, high levels of naproxen removal were detected (Wojcieszyńska, 
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et al., 2014). Another study used a pure isolate from activated sludge and co-metabolism to 
degrade ibuprofen and found that the isolate was more successful at degrading ibuprofen in the 
presence of other carbon sources (Almeida et al., 2013). The issue with using co-metabolism is 
that researchers are often skeptical about adding alternative carbon sources to treat water, 
especially phenol. Therefore, microorganisms in natural ecosystems should be explored in more 
detail since these organisms are being exposed to pharmaceutical compounds in their natural 
habitat. Four 17β-estradiol-degrading bacterial strains were isolated from natural sources (Zhou 
et al., 2013). A different study reported that acetaminophen has the potential to be biodegraded 
by 80% in a natural water system (Yamamoto et al., 2009). These studies emphasize the 
importance of investigating further the degradation capability of microorganisms that are 
naturally occurring in surface waters and sediments to help support an integrated strategy for the 
protection of ecosystems and human health (Nikolaou et al., 2007), and provide a better 
understanding of the bacteria that are degrading pharmaceuticals in the natural environment.  
 
Purpose of Study 
 
The overall purpose of this study was to culture bacteria from lake sediments associated 
with effluent discharges and determine if these isolates had the capability of growing on and 
degrading selected pharmaceuticals. The objectives were to conduct a variety of experiments to 
determine the growth and degradation potential of isolates as well as their versatility to grow on 
and degrade more than one compound. Versatility was an important measure in this study 
because a variety of pharmaceuticals are being released into surface waters simultaneously. The 
last objective was to determine if high capacity isolates have the ability to degrade compounds in 
their natural waters. This would give insight into whether native bacteria are utilizing 
pharmaceuticals under natural conditions. To the best of my knowledge, this is one of the first 
studies conducted that has cultured native bacteria from sediments sources and determined their 
growth and degradation potential on a variety of pharmaceuticals under both laboratory and more 
natural conditions.  
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Methods 
 
Overview 
 
 Water and sediment samples were collected from three locations on Lake Ontario’s south 
shoreline and one location on Onondaga Lake. Onondaga Lake, Durand Beach, Charlotte Beach, 
and Payne Beach were all chosen as sampling locations because of their close proximity to 
WWTP effluent discharges. These locations were sampled during the summer of 2015, the fall of 
2015, and the winter of 2016. During each season, an isolation approach was performed using 
serial enrichment in mineral medium containing 2.5 mg of each individual pharmaceutical as the 
sole carbon source available to heterotrophs. After four weeks of enrichment, bacteria were 
isolated and the growth of each isolate on selected pharmaceutical source was measured at 600 
nm. The biodegradation of pharmaceuticals was then examined with the isolates that showed the 
most consistent growth. Lastly, the growth and biodegradation potential of high capacity isolates 
were measured in their natural waters.  
 
Site Descriptions 
 
Onondaga Lake is located in Syracuse, NY, along the northern side of the city. The lake 
covers an area of 7.4 kilometers (km) and receives water from a drainage basin of approximately 
738 km2 (EPA, 2016b) as well as effluent discharges from the Metropolitan Syracuse 
Wastewater Treatment Plant (Onondaga Lake Partnership, 2010).  
For 125 years, municipal sewage and industrial waste were dumped into Onondaga Lake, 
which became heavily contaminated with compounds such as mercury, polychlorinated 
biphenyls, pesticides, heavy metals, and volatile organic compounds (Onondaga Lake 
Partnership, 2010). As a result, low oxygen levels and elevated levels of nutrients, disease-
causing microorganisms, and toxic contaminants became prevalent throughout the lake 
(Onondaga Lake Partnership, 2010). Onondaga Lake eventually became an EPA Superfund Site 
and has recently been remediated. Improvements have included wastewater upgrades and 
cleanup of the industrial pollution. Since 1990, the WWTP’s capacity to treat wastewater has 
improved through projects such as aeration and digital system upgrades (Onondaga Lake 
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Partnership, 2010). Lower concentrations of nutrients and contaminants have been reported since 
2007, improving the lake’s conditions (Onondaga Lake Partnership, 2010). However, stormwater 
runoff and wind have continued to assist in transporting non-point sources of pollution into the 
lake. Common sources of pollution are associated with agriculture and urbanization activities, 
including over-grazed pastures and unstabilized barnyards (Onondaga Lake Partnership, 2010).   
Durand Beach lies on Lake Ontario’s south shoreline in Irondequoit, NY. The beach 
receives several outfalls along the shoreline, including effluent discharges from the Van Lare 
Wastewater Treatment Plant, which is located approximately 0.64 km away. Field investigations 
done by the Monroe County Health Department have showed that the outfalls are from sewer 
pipes and natural tributaries that encompass the entire length of the beach (McEntire et al., 
2010). Two tributaries in particular, Camp Eastman and Sherry Swamp, contribute high densities 
of E. coli to the near shore waters of the beach, especially during heavy storm events (McEntire 
et al., 2010). E. coli densities often exceeded the 235 colonies/100 mL standard for a single 
sample (McEntire et al., 2010). During the 2006-2009 Operating Season, Durand Beach was 
closed for a total of 105 days with water clarity and percentage of bacteria listed as the main 
reasons for closure (McEntire et al., 2010).  
Charlotte Beach lies on the south shoreline of Lake Ontario in Rochester, NY. The beach 
receives outfalls from both the Van Lare WWTP and the Northwest Quadrant WWTP as well as 
the Genesee River. The Genesee River Watershed is associated with many water quality 
concerns stemming from urban and industrial sources, along the northern part of the watershed, 
and agricultural and other nonpoint sources, along the rural areas of the watershed (NYSDEC, 
n.d.). Charlotte Beach is often reported as a “repeat offender” by the Natural Resource Defense 
Council (NRDC) for having persistent contamination problems and high bacterial counts (Dyer, 
2014). Charlotte Beach has violated public health standards more than 25 percent of the time for 
each year spanning from 2009 to 2013 (Dyer, 2014). Decaying algae, typically Spirogyra and 
Cladophora, is often cited as a persistent contributor of fecal coliforms to the Charlotte Beach 
shoreline (Monroe County Department of Health, 2002).  
Payne Beach also lies on Lake Ontario’s south shoreline in Hilton, NY. The beach 
receives outfalls from the Northwest Quadrant Treatment Plant, which is located approximately 
1.1 km away. There have been no available reports regarding contamination problems at Payne 
Beach.  
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Sampling  
 
 The Lake Ontario samples were collected in the summer (May 28, 2015), fall (September 
22, 2015), and winter (March 8, 2016). The winter sample for Charlotte Beach was collected on 
March 29, 2016, since both the beach and lakeshore were frozen over on March 8th. The 
Onondaga Lake samples were collected in the summer (June 3, 2015), fall (September 20, 2015), 
and winter (February 28, 2016). All of the surface water samples that were used to test the 
growth of each isolate in their native waters were collected on August 15, 2016. The monthly 
precipitation rates for both the Rochester and Syracuse regions were recorded to determine if the 
water levels at each site were normal during sampling (Tables S-1a, S-1b).  
 The Onondaga Lake samples were collected approximately 4.0 km from an outfall pipe 
associated with the Metropolitan Syracuse WWTP (Figure 2). The samples were collected near a 
drainage area next to Onondaga Lake Parkway. The Payne Beach samples were collected near 
one of the outfalls associated with the Northwest Quadrant Treatment Plant, at the west end of 
the Braddock Bay Wildlife Refuge (Figures 3a, 3b). The Charlotte Beach samples were collected 
approximately 0.8 km from the Genesee River outfall and outfall pipes associated with the Van 
Lare and Northwest Quadrant WWTPs (Figures 3a, 3c). Lastly, the Durand Beach samples were 
collected directly across from the Van Lare WWTP on Lakeshore Boulevard (Figures 3a, 3d).  
A 2 m long graduated dipper with a 500 mL cup was used to collect the samples (Figure 
S-1). 500 mL of sediment and 500 mL of water were collected at each location. All samples were 
collected approximately 0.6-0.9 m from the shoreline and 7.6-10.2 cm deep into the sediment. 
Samples were placed in 1 L HDPE bottles and stored in a refrigerator set at 1.7°C. The 
temperature, pH, nitrate, and phosphate of all of the surface water samples (August 15, 2016) 
were taken and recorded (Table S-2).  
 
Enrichment Technique  
 
The enrichment test was carried out in 250 mL culture flasks containing 37 mL of 
Bushnell-Haas medium (HiMedia Laboratories Pvt. Ltd. India), 4 mL of sediment sample, and a 
concentration of 60 µg/mL of each individual pharmaceutical. The concentration implemented 
was based on a previous study in which concentrations of 50 µg/mL to 4500 µg/mL of 
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acetaminophen were used on pure bacterial strains (Zhang et al., 2013). All flasks were 
incubated in a shaking incubator (120 rpm) at room temperature for 7 days. Each of the four 
original samples were serially diluted and plated to R2A agar (BD Difco R2A agar; Sparks, MD, 
USA). Plates were stored in a room temperature incubator for up to 7 days. This approach was 
followed for weeks 2, 3, and 4. A diagram of the approach is represented in Figure 4. At week 5, 
all of the different colony types were picked from the week 4 plates and streaked to R2A plates. 
Plates were incubated at room temperature for 2-3 days. Isolates were then parafilmed and stored 
in a cold room (4°C) for further use. Isolates were named with a letter and number designation, 
and a subscript to represent from which season it was cultured (S represents summer, F 
represents fall, and W represents winter). Isolates with the same letter and/or number designation 
from the different seasons do not represent similarity. It is important to note that 17β-estradiol 
was only tested on the fall and winter samples.  
 
Growth of Isolates on Pharmaceutical Sources 
 
Isolates were inoculated into 10 mL of nutrient broth in 125 mL flasks and incubated for 
2 days in a room temperature shaking incubator (120 rpm). After 2 days, the isolates were 
harvested by centrifugation (15,000 rpm for 5 minutes) and re-suspended into 2 mL of Bushnell-
Haas medium. 9.8 mL of Bushnell-Haas medium was added to the 125 mL flask. 0.2 mL of cells 
were added to the 125 mL flask with a concentration of 750 µg/mL of the selected 
pharmaceutical. The concentration implemented was increased after performing preliminary 
studies with 250 µg/mL and 500 µg/mL concentrations. A control series was run for each 
pharmaceutical tested. Each control consisted of 10 mL of Bushnell-Haas medium and a 
concentration of 750 µg/mL of the selected pharmaceutical. All cultures were incubated in a 
shaking incubator (120 rpm) at room temperature for 10 days. Samples were taken at 0, 2, 4, 6, 8, 
and 10 days. At each time interval, 0.3 mL samples were taken and the absorbance was read at 
600 nm. Isolates that grew well on their respective pharmaceuticals were further tested on the 
other pharmaceuticals and in their natural waters. For the natural water tests, the Bushnell-Haas 
media was replaced with 9.8 mL of the unfiltered natural water source from which each isolate 
originated. 0.2 mL of cells and a concentration of 750 µg/mL of the selected pharmaceutical 
were added to the 125 mL natural water flask. Two control series’ were tested: 1) 0.2 mL of cells 
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with 10 mL of the natural water in which the isolate originated, and 2) a concentration of 750 
µg/mL of the selected pharmaceutical with 10 mL of the natural water in which the isolate 
originated. The same incubation and sampling protocol was followed as outlined.  
 
Growth Analysis 
 
The growth of each isolate on its respective pharmaceutical source were read at 600 nm 
on a UV/VIS spectrophotometer. The 0.3 mL samples were diluted with 2 mL of Bushnell-Haas 
media. The absorbance of each sample was multiplied by 5 to account for the dilutions.  
The growth rate (k) of each isolate was determined by first calculating the generation 
time (G) of cells [1]. The duration period of each isolate was considered over a 2-day period of 
growth (N1 represents the lower absorbance, N2 represents the higher absorbance). The growth 
rate was then calculated using the generation time that was determined for each isolate [2].  
 
[1] G =
𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛∗𝑙𝑜𝑔10(2)
𝑙𝑜𝑔10(𝑁2)−𝑙𝑜𝑔10(𝑁1)
 
 
[2] 𝑘 =  
0.693
𝐺
 
 
Biodegradation of Pharmaceuticals as Measured by Carbon Dioxide  
 
Isolates were inoculated into 10 mL of nutrient broth in 125 mL flasks and incubated for 
2 days in a room temperature shaking incubator (120 rpm). After 2 days, the isolates were 
harvested by centrifugation (15,000 rpm for 5 minutes) and re-suspended into 2 mL of Bushnell-
Haas medium. 50 mL of Bushnell-Haas were added to a biometer flask (Figure 5). 1 mL of cells 
were added to the flasks with 7.5 mg of the selected pharmaceutical. Ascarite, which absorbs 
carbon dioxide, was added to the flask tower and 10 mL of Potassium hydroxide (KOH) was 
added to the sidearm. A control series was run for each pharmaceutical tested. Each control 
consisted of 51 mL of Bushnell-Haas medium and 7.5 mg of the selected pharmaceutical. All 
flasks were incubated in a non-shaking incubator at room temperature for 10 days. Samples of 
KOH were taken and carbon dioxide evolution was measured at 2, 4, 6, 8, and 10 days. At each 
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time interval, the KOH was withdrawn from the sidearm and transferred to a separate 125 mL 
flask and the sidearm was refilled with 10 mL of fresh 0.2N KOH. 1 mL of saturated barium 
chloride and 0.1 mL of phenolphthalein were added to the 125 mL flask. Samples were titrated 
with 0.05N Hydrochloric acid (HCl) until the solutions turned colorless. This was compared to 
the unexposed KOH sitting at room temperature. Isolates that grew well on the other 
pharmaceuticals and in their natural waters were further tested. For the natural water tests, the 
Bushnell-Haas media was replaced with 51 mL of the unfiltered natural water source from which 
each isolate originated. 1 mL of cells and 7.5 mg of the selected pharmaceutical were added to 
the biometer flask. Two control series’ were tested: 1) 1 mL of cells with 51 mL of the natural 
water in which the isolate originated, and 2) 7.5 mg of the selected pharmaceutical with 51 mL 
of the natural water in which the isolate originated. The same incubation and sampling protocol 
was followed as outlined. 
 
Biodegradation Analysis 
 
The volume of HCl needed to neutralize the KOH was recorded. The volume of HCl 
needed to neutralize the experimental KOH was then subtracted from the volume needed to 
neutralize the unexposed KOH and multiplied by 25 to determine the micromoles (µmol) of 
carbon dioxide evolved [3]. A pharmaceutical control series and triplicates were run for each 
isolate tested. The average carbon dioxide evolved for each was calculated from the triplicate 
series’.  
The percent biodegradation for each isolate was calculated using the average micromoles 
of carbon dioxide evolved by each isolate and each pharmaceutical control. The average carbon 
dioxide evolution from the pharmaceutical control series was subtracted from the average carbon 
dioxide evolution of each isolate series [4]. The number of micromoles evolved by each isolate 
was converted into mg [5]. The moles of carbon present in the selected pharmaceuticals was 
calculated from the molecular weight of each compound and multiplied by 7.5 mg [6]. The mg of 
carbon evolved by each isolate was then divided by the mg of carbon in each selected 
pharmaceutical and multiplied by 100 to find the percent biodegradation [7]. 
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[3] 𝐶𝑂2(𝜇𝑚𝑜𝑙) = (𝑉𝑜𝑙𝑢𝑚𝑒(𝑚𝐿)(𝑢𝑛𝑒𝑥𝑝𝑜𝑠𝑒𝑑) − 𝑉𝑜𝑙𝑢𝑚𝑒(𝑚𝐿)(𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙)) 𝑥 25 
 
[4] ?̅?𝐶𝑂2(𝜇𝑚𝑜𝑙) = ?̅?𝐶𝑂2(𝜇𝑚𝑜𝑙)(𝑖𝑠𝑜𝑙𝑎𝑡𝑒) − ?̅?𝐶𝑂2(𝜇𝑚𝑜𝑙)(𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙 𝑐𝑜𝑛𝑡𝑟𝑜𝑙) 
 
[5] 𝐴𝑚𝑜𝑢𝑛𝑡 𝐶𝑎𝑟𝑏𝑜𝑛 (𝑚𝑔)(𝑖𝑠𝑜𝑙𝑎𝑡𝑒)  = ?̅?𝐶𝑂2(𝜇𝑚𝑜𝑙) 𝑥 
10−6 𝑚𝑜𝑙
𝜇𝑚𝑜𝑙
𝑥 
12 𝑔 𝐶
1 𝑚𝑜𝑙
 𝑥 1000 𝑚𝑔 𝑥 0.27 
 
[6] 𝐴𝑚𝑜𝑢𝑛𝑡 𝐶𝑎𝑟𝑏𝑜𝑛 (𝑚𝑔)(𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙) =
𝐴𝑚𝑜𝑢𝑛𝑡 𝐶𝑎𝑟𝑏𝑜𝑛 (
𝑔
𝑚𝑜𝑙
)
𝑀𝑊 𝑜𝑓 𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙 (
𝑔
𝑚𝑜𝑙
)
 𝑥 7.5 𝑚𝑔 
 
[7] % 𝐵𝑖𝑜𝑑𝑒𝑔𝑟𝑎𝑑𝑎𝑡𝑖𝑜𝑛 =
𝐴𝑚𝑜𝑢𝑛𝑡 𝐶𝑎𝑟𝑏𝑜𝑛 (𝑚𝑔)(𝑖𝑠𝑜𝑙𝑎𝑡𝑒)
𝐴𝑚𝑜𝑢𝑛𝑡 𝐶𝑎𝑟𝑏𝑜𝑛 (𝑚𝑔)(𝑝ℎ𝑎𝑟𝑚𝑎𝑐𝑒𝑢𝑡𝑖𝑐𝑎𝑙)
 𝑥 100 
 
 
***It is important to note that these calculations do assume complete degradation of 
contaminants and do not take into account the potential metabolic products.  
 
Statistical Analysis 
 
 Using sampling season as the replicate (n = 3 seasons), the number of colony-forming 
units (cfu/mL) and colony diversity for each pharmaceutical were evaluated using one-way 
ANOVA with sampling site as the fixed factor. The amount of CO2 evolved by isolates under 
natural conditions were evaluated using one-way ANOVA with specific measure (experimental 
or control test) as the fixed factor. Following these analyses, a post-hoc Tukey HSD and a Fisher 
LSD test were performed to identify sample means that were significantly different from one 
another. 
 
 
 
 
 
 
 
 
 
 
 
14 
Results 
 
Cell Enrichment 
 
The average cfu/mL and diversity of heterotrophs were determined for each sampling 
site. A one-way ANOVA test indicated that the average cfu/mL growing on acetaminophen 
significantly differed between sites (p < 0.05) (Table S-3b). A post-hoc Tukey HSD test 
determined that Durand Beach had a significantly greater number of cfu/mL growing on 
acetaminophen than both Payne Beach and Onondaga Lake (Table S-3a). The average number of 
cfu/mL from Durand Beach utilizing acetaminophen was 1.3x108 after four weeks of enrichment 
(Table S-3a). The post-hoc test also indicated that the number of cfu/mL from Charlotte Beach 
growing on acetaminophen could not be significantly differentiated from the three other sites 
(Table S-3a). A one-way ANOVA test indicated that the average cfu/mL growing on ibuprofen 
also significantly differed between sites (p < 0.05) (Table S-3b). Although significance was 
determined, a post-hoc Tukey test failed to indicate which sites differed. Therefore, a Fisher LSD 
test was performed, and it was determined that Durand Beach had a significantly greater number 
of cfu/mL growing on ibuprofen than both Payne Beach and Onondaga Lake (Table S-3a). 
However, this test also indicated that the number of cfu/mL from Charlotte Beach growing on 
ibuprofen could not be differentiated from the three other sites (Table S-3a). One-way ANOVA 
and post-hoc tests indicated that there were no significant differences between the sites and the 
number of cfu/mL growing on both naproxen and 17β-estradiol (p > 0.05) (Table S-3a, S-3b). 
One-way ANOVA and post-hoc tests determined that there were no significant differences 
between the sampling sites and the diversity of colonies growing on the selected pharmaceuticals 
(p > 0.05) (Table S-4a, S-4b).  
 
Growth and Biodegradation of Acetaminophen by Initial Isolates 
 
The growth of isolates initially enriched on acetaminophen was assessed for each 
sampling site. There were a number of isolates from each site that exhibited no growth, long lag 
phases, or rapid die-off when acetaminophen was administered (Table 1). These isolates were 
not further studied as a result. However, a number of bacteria from each site were capable of 
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growing on acetaminophen. Isolate K4W, cultured from Durand Beach, exhibited the highest rate 
of growth on acetaminophen, with a growth rate of 1.55/day (Table 1). A number of isolates 
cultured from Payne Beach demonstrated high rates of growth on acetaminophen (Table 1). N1S 
and E1W were two isolates in particular that sustained growth rates of 1.22/day (Table 1). Isolates 
that displayed consistent rates of growth and absorbance on acetaminophen were further studied. 
A growth curve of isolates utilizing acetaminophen is represented in Figure 6. In several 
instances, the mixture in the flask turned a dark brown color over the test period, suggesting that 
a number of isolates oxidized the acetaminophen when administered (Figure 7). 
The rates of degradation by isolates initially enriched on acetaminophen were then 
assessed. There were a number of isolates from each site that displayed variable rates of growth 
on acetaminophen (Table 2). These isolates were not further studied because of their lack of 
consistency. However, there were a number of bacteria that were capable of degrading 
acetaminophen (Table 2). A majority of these isolates were cultured from Payne Beach. N1S and 
L1F were two isolates in particular that could degrade acetaminophen by approximately 40% 
over the 10 days (Table 2). Isolates that exhibited consistent rates of degradation were further 
studied. The degradation of acetaminophen by various isolates is represented in Figure 8. Isolate 
N1S was capable of oxidizing acetaminophen, as shown in Figure 9.  
 
Growth and Biodegradation of Acetaminophen by Alternative Isolates 
 
Isolates that were capable of utilizing ibuprofen, naproxen, or 17β-estradiol were also 
assessed on acetaminophen. Isolates N3F and S2F, cultured from Payne Beach and Durand Beach 
respectively, were the only two alternative isolates that were capable of growing on 
acetaminophen (Table 1). In terms of degradation potential, isolate N3F was capable of degrading 
acetaminophen by approximately 28% and S2F was capable of degrading acetaminophen by 
approximately 29% (Table 2).  
 
Growth and Biodegradation of Ibuprofen by Initial Isolates 
 
The growth of isolates initially enriched on ibuprofen was assessed for each sampling 
site. There were a number of isolates from each site that exhibited no growth, long lag phases, or 
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rapid die-off when ibuprofen was administered (Table 3). These isolates were not further studied 
as a result. However, a number of bacteria from each site were capable of growing on ibuprofen. 
Isolate L4W, cultured from Durand Beach, exhibited the highest rate of growth on ibuprofen, 
with a growth rate of 1.52/day (Table 3). A number of isolates cultured from Onondaga Lake 
demonstrated consistent rates of growth on ibuprofen (Table 3). G1F and G4F were two isolates 
in particular that sustained growth rates of 0.58/day and 0.27/day, respectively (Table 3). Isolates 
that displayed consistent rates of growth and absorbance on ibuprofen were further studied.  
The rates of degradation by isolates initially enriched on ibuprofen were then assessed. 
There were a number of isolates from each site that displayed variable rates of growth on 
ibuprofen (Table 4). These isolates were not further studied because of their lack of consistency. 
However, a number of bacteria that were capable of degrading ibuprofen (Table 4). Isolate L4W 
was capable of degrading ibuprofen by approximately 25%, which was the highest percent 
degradation of ibuprofen found in this study (Table 4). Isolate B1W, cultured from Charlotte 
Beach, degraded ibuprofen by approximately 23% (Table 4). Isolates that exhibited consistent 
rates of degradation on ibuprofen were further studied.  
 
Growth and Biodegradation of Ibuprofen by Alternative Isolates 
 
Isolates that were capable of utilizing acetaminophen, naproxen, or 17β-estradiol were 
also assessed on ibuprofen. A number of isolates were capable of growing on ibuprofen (Table 
3). A majority of these isolates were cultured from both Payne Beach and Charlotte Beach. D1W 
and B1F were two isolates in particular that sustained growth rates of 0.57/day and 0.42/day, 
respectively (Table 3). Isolate N2W, cultured from Durand Beach, had the highest rate of growth 
on ibuprofen, with a growth rate of 1.18/day (Table 3). The degradation of ibuprofen by 
alternative isolates was also assessed. N2W was capable of degrading ibuprofen by approximately 
20% (Table 4). Isolate N1S had the highest degradation potential on ibuprofen, and degraded the 
compound by approximately 22% (Table 4).  
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Growth and Biodegradation of Naproxen by Initial Isolates 
 
The growth of isolates initially enriched on naproxen was assessed for each sampling site. 
There were a number of isolates from each site that exhibited no growth, long lag phases, or 
rapid die-off when naproxen was administered (Table 5). These isolates were not further studied 
as a result. However, a number of bacteria from Payne Beach and Durand Beach were capable of 
growing on naproxen. Isolates O2F and O3F, cultured from Payne Beach, exhibited the highest 
rates of growth on naproxen, with growth rates of 0.72/day and 0.79/day (Table 5). Isolates that 
displayed consistent rates of growth and absorbance on naproxen were further studied.  
The rates of degradation by isolates initially enriched on naproxen were then assessed. 
There were a select few isolates that displayed variable rates of growth on naproxen (Table 6). 
These isolates were not further studied because of their lack of consistency. However, there were 
a number of bacteria that were capable of degrading naproxen (Table 6). Isolate N1W was 
capable of degrading naproxen by approximately 27%, which was the highest percent 
degradation of naproxen found in this study by an isolate initially enriched on the compound 
(Table 6). Isolates that exhibited consistent rates of degradation on naproxen were further 
studied.  
 
Growth and Biodegradation of Naproxen by Alternative Isolates 
 
Isolates that were capable of consistently utilizing acetaminophen, ibuprofen, or 17β-
estradiol were also assessed on naproxen. A number of isolates were capable of growing on 
naproxen (Table 5). A majority of these isolates were cultured from Durand Beach. L1S, S2F, 
L4W, and N2W were all isolates in particular that displayed consistent growth on naproxen over 
the 10-day period (Table 5). Isolate N2W, cultured from Durand Beach, had the highest rate of 
growth on naproxen, with a growth rate of 1.09/day (Table 5). The degradation of naproxen by 
alternative isolates was also assessed. Isolates L1S, S2F, L4W, and N2W were all capable of 
degrading naproxen (Table 6). Isolate L4W had the highest degradation potential on naproxen, 
and degraded the compound by approximately 35% (Table 6).  
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Growth and Biodegradation of 17β-estradiol by Initial Isolates 
 
The growth of isolates initially enriched on 17β-estradiol was assessed for each sampling 
site. There were a number of isolates from each site that exhibited no growth, long lag phases, or 
rapid die-off when 17β-estradiol was administered (Table 7). These isolates were not further 
studied as a result. However, a number of bacteria from Durand Beach were capable of growing 
on 17β-estradiol. Isolates S2F and T2F were two isolates in particular that sustained growth rates 
of 0.32/day and 0.38/day (Table 7). Isolates that displayed consistent rates of growth and 
absorbance on 17β-estradiol were further studied.  
The rates of degradation by isolates initially enriched on 17β-estradiol were then 
assessed. There were a select few of isolates that displayed variable rates of growth on 17β-
estradiol (Table 8). These isolates were not further studied because of their lack of consistency. 
However, there were a number of bacteria that were capable of degrading 17β-estradiol (Table 
8). Isolate N2W, cultured from Durand Beach, was capable of degrading 17β-estradiol by 
approximately 27%, which was the highest percent degradation of 17β-estradiol found in this 
study by an isolate initially enriched on the compound (Table 8). Isolates that exhibited 
consistent rates of degradation on 17β-estradiol were further studied.  
 
Growth and Biodegradation of 17β-estradiol by Alternative Isolates 
 
Isolates that were capable of consistently utilizing acetaminophen, ibuprofen, or naproxen 
were also assessed on 17β-estradiol. A number of isolates were capable of growing on 17β-
estradiol (Table 7). B1W and L4W, cultured from Charlotte Beach and Durand Beach 
respectively, were two isolates in particular that displayed consistent growth on 17β-estradiol 
over the 10-day period (Table 7). Isolate L4W had the highest rate of growth on 17β-estradiol, 
with a growth rate of 0.45/day (Table 7). The degradation of 17β-estradiol by alternative isolates 
was also assessed. Isolates B1W and L4W were both capable of degrading 17β-estradiol by 
approximately 29% (Table 8).  
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Growth of High Capacity Isolates in Natural Water Systems 
 
The growth of high capacity isolates was tested on pharmaceuticals in their natural 
waters. High capacity isolates were those that were able to grow on and degrade more than one 
compound. There were a number of isolates from each site that exhibited no growth, long lag 
phases, or rapid die-off when the selected pharmaceuticals were administered in their natural 
waters (Table 9). These isolates were not further studied as a result. No isolates cultured from 
Onondaga Lake were capable of utilizing pharmaceuticals in their natural waters. However, a 
number of bacteria from the three other sites were capable of growing on the compounds (Table 
9). S2F, cultured from Durand Beach, was one isolate in particular that was capable of growing 
on both acetaminophen and ibuprofen in its natural water (Table 9). The isolate also exhibited 
higher overall growth rates than those of the tested controls (Table 9). Isolate E1W, cultured from 
Payne Beach, sustained a growth rate of 0.80/day on acetaminophen in its natural water (Table 
9). However, isolate E1W was unable to grow on 17β-estradiol in its natural water (Table 9). In 
fact, no isolate was capable of growing on 17β-estradiol in its natural water.  
 
Biodegradation of Pharmaceuticals by High Capacity Isolates in Natural Water   
 
Following growth analysis, the degradation of pharmaceuticals by high capacity isolates 
in natural waters was assessed. The degradation of naproxen by isolate L1S and its associated 
controls is represented in Figure 11. A majority of isolates tested were incapable of degrading the 
selected pharmaceuticals to significant levels (p > 0.05) (Table 10, Figure 10). However, there 
were a select few that were capable of degrading the selected pharmaceuticals to significant 
levels (p < 0.05) (Table 10, Figure 10). B1W, E1W, and N2W were three isolates in particular 
(Table 10, Figure 10). However, the mean micromoles of CO2 evolved by these isolates on their 
selected pharmaceuticals only significantly differed from one of the tested controls (Figure 10). 
That being said, the total degradation of naproxen by isolate B1W was significantly different 
from naproxen in Durand Beach water solely, but was similar to B1W in Durand Beach water 
solely (Figure 10). The total degradation of acetaminophen by isolate E1W was significantly 
different from acetaminophen in Payne Beach water solely, but was similar to E1W in Payne 
Beach water solely (Figure 10). Lastly, the total degradation of ibuprofen by N2W was 
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significantly different from N2W in Durand Beach water solely, but was similar to ibuprofen in 
Durand Beach water solely (Figure 10).  
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Discussion 
 
Enrichment of Bacteria from Natural Environments 
 
The removal of emerging contaminants from surface waters is of great practical 
significance. In this study, microorganisms capable of using various pharmaceuticals as their sole 
carbon sources were readily isolated from lake sediments associated with wastewater effluent 
discharges. This was of no surprise given that pharmaceuticals are increasingly being detected in 
surface waters at higher rates. The enrichment studies of this experiment illustrate that all four 
sampling sites are able to sustain large bacterial communities as indicated by the average cfu/mL 
counts (Tables S-3a), consisting of a mix of gram negative and gram positive bacteria (Table 11, 
Figure 12, Figure S-2(a-c)). As a result, a variety of bacteria were assessed on the selected 
pharmaceuticals during this study.  
By sampling different seasons, it was revealed that the number of colony-forming units 
and the overall diversity of the colonies growing on the selected pharmaceuticals did not 
significantly differ between seasons (p > 0.05). This suggests that the number and diversity of 
bacteria in the four sampling sites are consistent over the three seasons. However, by sampling 
different sites, it was revealed that the number of cfu/mL did significantly change between sites, 
depending on the pharmaceutical being tested (p < 0.05) (Table S-3a, S-3b). That being said, the 
number of cfu/mL on both acetaminophen and ibuprofen individually, were found to be 
significantly different at Durand Beach as compared to Onondaga Lake and Payne Beach (Table 
S-3a). This data suggests that there may be more acetaminophen and ibuprofen being released 
into Durand Beach than both Onondaga Lake and Payne Beach. Durand Beach receives several 
outfalls along its shoreline, including those from sewer pipes and the Van Lare WWTP, which 
may be leading to an increased release of both acetaminophen and ibuprofen. This may be 
causing a significant increase in the number of bacteria present at Durand Beach capable of 
utilizing these two compounds. However, it was revealed that the diversity of bacteria did not 
change between sites (p > 0.05) (Table S-4a, S-4b). This suggests that there are similar types of 
bacteria present at each of the four locations, which was of no surprise given that three of the 
four sampling locations lie on Lake Ontario’s south shoreline.  
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Growth of Isolates on Selected Pharmaceuticals 
 
Following the enrichment tests, the growth of isolated bacteria on pharmaceuticals was 
assessed. This was a way to eliminate isolates that demonstrated little potential of utilizing the 
pharmaceuticals as their sole carbon sources. Several isolates, both those that were initially 
enriched on specific pharmaceuticals or those that were tested on alternative pharmaceuticals, 
were unable to sustain growth on administered compounds. These isolates may have been able to 
survive the enrichment technique, in which a concentration of 60 µg/mL of pharmaceuticals 
were used, but were unable to survive during the growth tests, in which higher concentrations of 
pharmaceuticals were implemented. Overall, the growth experiments in this study revealed a 
variety of isolates from the four sampling sites that were capable of growing on the selected 
pharmaceuticals under both laboratory conditions and more natural conditions. This was of no 
surprise given the increased prevalence of pharmaceuticals in surface waters and the malleability 
of microbes. As a result, the isolates that were capable of growing on specific pharmaceuticals 
were assessed and their overall ability to remove the compounds was determined. 
 
Biodegradation of Selected Pharmaceuticals Under Laboratory Conditions 
 
It has been suggested that the biodegradability toward certain compounds could be a 
result of the adaptation of microbial communities to chemical contamination in the past or 
present (Nishihara et al., 1997). Generally speaking, the release of pharmaceuticals in effluents 
may play a factor in the degradation capability of bacteria present at specific locations. In this 
part of the study, the degradation of pharmaceuticals by isolates from each site were assessed 
under laboratory conditions. A large number of bacteria from all four sampling sites were 
capable of degrading the selected compounds.  
Durand Beach sustained a large number of bacteria that were capable of degrading the 
pharmaceuticals tested. This suggests that the release of pharmaceuticals into the environment 
may be capable of inducing a high number of pharmaceutical-degrading bacteria. Isolate L4W 
was capable of degrading 17β-estradiol by 29%, ibuprofen by 25%, and naproxen by 35% and 
isolate N2W was capable of degrading ibuprofen by 20%, 17β-estradiol by 27%, and naproxen by 
26%. Payne Beach sustained a large number of bacteria that were capable of degrading 
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acetaminophen. Both isolates N1S and L1F were capable of degrading acetaminophen by 
approximately 40% whereas N3F was capable of degrading acetaminophen by approximately 
28%. Isolate B1W, cultured from Charlotte Beach, was capable of degrading ibuprofen by 23%, 
naproxen by 32%, and 17β-estradiol by 29%. Onondaga Lake did not sustain as many isolates 
that were capable of degrading the pharmaceuticals; however, G1F was capable of degrading 
ibuprofen by 20% and G4F was capable of degrading both ibuprofen and naproxen by 18% and 
28%, respectively.  
The results of these experiments indicate that pharmaceutical-degrading bacteria are 
present in lake sediments, and can be used to degrade pharmaceuticals under laboratory 
conditions. However, testing their capability to utilize pharmaceuticals under more realistic 
conditions is practical to determine how they are playing a role in the removal of these 
compounds in the environment.  
 
Biodegradation of Selected Pharmaceuticals Under More Realistic Conditions 
 
In order to translate the laboratory results into more realistic results, the degradation of 
selected pharmaceuticals under more natural conditions was assessed. To date, there are a lack of 
studies that incorporate laboratory-scale biodegradation tests with natural water (Yamamoto et 
al., 2009). In this part of the study, the only bacteria assessed were those that showed consistent 
degradation rates on pharmaceuticals and versatility under laboratory conditions. Although a 
number of isolates were capable of degrading selected compounds under laboratory conditions, 
the overall removal efficiencies of compounds by the majority of isolates tested under natural 
conditions were not significant in relation to the controls (p > 0.05) (Table 10, Figure 10). This 
suggests that certain types of bacteria may not be as adaptive in utilizing pharmaceuticals in 
natural sources and are finding easier ways to obtain carbon. However, three isolates were able 
to significantly degrade the selected compounds (p < 0.05) (Table 10, Figure 10). However, these 
results also brought about skepticism. Although isolate N2W evolved significantly more 
micromoles of CO2 on ibuprofen than the N2W and water control, N2W did not evolve 
significantly more CO2 on ibuprofen than the ibuprofen and water control (Figure 10). This 
suggests that the activity of N2W may have been enhanced when ibuprofen was administered, or 
that there are other bacteria in the water that are compensating for the ibuprofen release. More 
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studies would have to be implemented in order to determine the exact result. In relation to this, 
although isolate E1W evolved significantly more micromoles of CO2 on acetaminophen than the 
acetaminophen and water control, E1W did not evolve significantly more CO2 on acetaminophen 
than the E1W and water control (Figure 10). However, that being said, it is likely that isolate E1W 
does have the capability of removing acetaminophen in its natural waters because the 
acetaminophen and E1W mixture turned a dark brown color during the experimental test whereas 
the E1W and water control did not. These results indicate that E1W has the capability of oxidizing 
acetaminophen as well as utilizing other carbon sources when acetaminophen is not present. 
Lastly, although isolate B1W evolved significantly more micromoles of CO2 on naproxen than 
the naproxen and water control, B1W did not evolve significantly more CO2 on naproxen than the 
B1W and water control (Figure 10). This suggests that B1W may have the capability of utilizing 
naproxen as well as other carbon sources when in its natural environment; however, more studies 
would have to be implemented in order to determine the exact result.  
Durand Beach, Payne Beach, and Charlotte Beach likely have bacteria present that are 
helping to compensate for the release of pharmaceuticals into their environments. The release of 
pharmaceuticals into these environments may be influencing the community structure of 
organisms that live on these particular contaminants. Given that the number of colonies growing 
on ibuprofen was significant at Durand Beach, it can be assumed that a significant amount of 
ibuprofen is being released into the environment along Durand’s shoreline. The increased load of 
ibuprofen may be selecting for certain types of bacterial communities. Isolate N2W was one 
isolate in particular that was capable of utilizing ibuprofen under natural conditions. This 
suggests that isolate N2W may be aiding in the removal of ibuprofen from Durand Beach. Isolate 
B1W may be a promising for Charlotte Beach as it is capable of degrading naproxen to lower 
loads than applied. The Genesee River drains into Charlotte Beach, which may be releasing 
pharmaceutical residues, especially naproxen, into the beach area. No isolates from Onondaga 
Lake were capable of degrading selected pharmaceuticals under natural conditions. This may be 
due to a variety of environmental factors or to the location in which the water was sampled. The 
history of Onondaga Lake may also explain the differences, since the chemistry of the lake may 
not have yet bounced back. Lastly, 17β-estradiol was not utilized by any of the bacterial isolates 
during the implemented water tests, which may be due to its complexity as a compound. It is also 
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important to note that all of the selected compounds may change composition in natural habits 
and/or form microbial byproducts, which are often harder for bacteria to utilize.  
Overall, the degradations of ibuprofen, naproxen, and acetaminophen were lower than 
those found under laboratory conditions. This was expected and likely due to the introduction of 
environmental factors that were essentially void under the laboratory tests. In natural 
environments, bacteria are often limited by the extremes of pH and temperature, the lack of 
nutrients, and the toxicity of some compounds (USGS, 2007). pH variations in natural systems 
can significantly impact the activity of bacteria. Therefore, the environmental characteristics of 
the sampled water were evaluated to see if the water’s conditions may have played a factor on 
the behavior of isolated bacteria in this study. The pH of each sampling site was between 8.25 
and 8.61 (Table S-2). Onondaga Lake and Charlotte Beach both had pH’s of 8.61, which may 
have been due to runoff and/or discharges into the edges of these surface waters. Considering a 
bacterium from Charlotte Beach (B1W) was able to degrade naproxen to lower levels than 
applied, it is predicted that the bacteria present at this site may be adapted to higher pH levels. 
However, a bacterium from Onondaga Lake (G4F) was incapable of utilizing both ibuprofen and 
naproxen in water, which may be a result of the pH level. As for temperature, seasonal variations 
can often influence the nature of microbial communities. It has been suggested that the ideal 
temperatures for bacterial activity are in the range of 25°C to 35°C (Metcalf and Eddy, 2003). In 
this study, the temperatures of all four sampling sites were within the optimum temperature 
range of bacterial activity. Lastly, both nitrate and phosphate levels were measured to be low in 
these systems, which should not have had a significant impact on microbial activity.   
 
Characteristics of Promising Isolates 
 
A handful of bacteria from previous studies have been identified that have the capability 
of degrading a variety of pharmaceuticals. In fact, several sphingomonads have been found to 
degrade xenobiotics including ibuprofen (Murdoch and Hay, 2005) and 17β-estradiol (Kurisu et 
al., 2010; Yu et al., 2007). Sphingomonas sp and Sphingobium sp are gram negative rods. In this 
study, several bacteria from each site capable of degrading ibuprofen were identified as gram 
negative rods, including J2S, B1F (Figure 12), and B1W. Along with sphingomonads, several other 
species have been isolated from effluents that can degrade 17β-estradiol, including Isoptericola 
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sp (gram positive, rods or cocci), Nubsella sp (yellow-pigmented, gram negative, rods), and 
Rhodococcus sp (gram positive, rods) (Zhou et al. 2013), and Acinetobacter sp (gram negative, 
bacilli) (Pauwels et al., 2008). Most of the bacteria capable of degrading 17β-estradiol in this 
study were gram negative rods. One isolate in particular was S2F (Figure S-2b), which was a 
yellow-pigmented, gram negative rod. Based off of these characteristics, S2F is likely to be a 
Nubsella sp. Sphingomonas sp have also been shown to degrade naproxen (Zhou et al., 2013). In 
this study, a mix of gram negative and gram positive bacteria were found to degrade naproxen. 
For example, N3F, B1W, and L4W were all examples of gram negative rods that were capable of 
degrading naproxen to various levels and N1W was a gram positive rod. Lastly, some 
pseudomonas sp (gram negative, rods) have the capability of degrading acetaminophen (Hu et 
al., 2013). Again, a mix of gram negative and gram positive bacteria were found that were 
capable of degrading acetaminophen. The top degraders of acetaminophen were a gram positive 
cocci (N1S, (Figure 12)) and gram negative rods (L1F and E1W). 
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Conclusion 
 
 Pharmaceuticals and their metabolites are increasingly being detected in the environment 
since the common WWTP is insufficient in completely eliminating these drugs. It has been 
suggested that the rate at which pharmaceuticals are removed from the environment depends on 
the presence of natural microbial populations able to degrade them (Caracciolo et al., 2015). In 
fact, repeated exposure of microbial populations to such compounds may enhance the activity of 
microbes and reduce the persistence of compounds (Caracciolo et al., 2015). Our results 
demonstrate that under laboratory conditions, there are a variety of bacteria that are capable of 
utilizing ibuprofen, naproxen, acetaminophen, and 17β-estradiol as their sole carbon sources; 
thus, reducing these compounds to lower levels than administered. Under more realistic 
conditions, a select number of bacteria were also capable of degrading ibuprofen, naproxen, and 
acetaminophen in their natural environments. This suggests that the release of pharmaceuticals 
into the sampling sites may be influencing the community structure of organisms that live on 
these particular contaminants. Thus, going forward, a variety of studies could be implemented to 
better understand the environmental fate of emergent compounds and their overall risks to the 
environment. Determining the metabolic products of parent compounds is important, since 
metabolites could be more persistent and present in concentrations even higher than their parent 
compounds (Radjenović et al., 2008). Many pharmaceuticals are present in the environment 
simultaneously as well (Nikolaou et al., 2007); therefore, studies should also be implemented to 
determine how microbial communities may manage a mixture of such compounds. That being 
said, a consortium of bacterial isolates should be tested with pharmaceuticals to determine if 
cooperative mechanisms are involved in the degradation of these products, and if byproducts are 
produced in return. Molecular analysis of isolated strains should also be determined to identify 
which bacteria may be induced by pharmaceutical presence in the environment.  
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Tables 
 
Table 1. Growth of isolates on acetaminophen. The final absorbance and growth rate were 
determined at the 10-day mark. The final absorbance was taken at 600 nm. The growth rate 
represents days-1. Not determined (N/D) = No growth and/or immediate die-off, † = Longer than 
4-day lag phase, ‡ = Growth, but die-off period(s), * = Initial pharmaceutical particular isolates 
were enriched on. The isolates in gray were chosen for further testing.  
Isolate Isolate Origin 
 
Final Absorbance Growth Rate 
Summer    
Control  0.15 N/D 
*B1S Charlotte 0.055 N/D 
*B2S Charlotte 0.235 0.18
† 
*C1S Charlotte 0.85 0.24
† 
*F1S Onondaga 1.49 1.36 
*F2S Onondaga 0.115 N/D 
*G1S Onondaga 5.28 1.17 
*J1S Durand 5.78 0.91 
*N1S Payne 1.6 1.22 
*N2S Payne 0.07 N/D 
*O1S Payne 3.97 0.98 
*O2S Payne 1.28 0.45 
*R2S Onondaga 1.17 0.64 
*S2S Charlotte 0.815 0.34 
J2S Durand 0.13 N/D 
L1S Durand 0.26 0.21
‡ 
L2S Payne 0.98 0.17
† 
Fall    
Control  0.025 N/D 
 *A1F Charlotte 5.855 0.97 
*A3F Charlotte 8.44 1.21 
*A4F Charlotte 2.41 0.65
‡ 
*B1F Charlotte 5.235 1.18 
*E2F Onondaga 0.29 0.19
† 
*F2F Onondaga 0.27 0.26 
*I1F Durand 0.08 N/D 
*I2F Durand 0.16 0.13
† 
*L1F Payne 6.545 0.72 
*L3F Payne 0.62 N/D 
*M1F Payne 0.3 0.39
† 
*M2F Payne 6.69 0.87 
G1F Onondaga 0.25 0.61
† 
G4F Onondaga 0.32 0.39
† 
N3F Payne 4.5 1.16 
S2F Durand 1.82 1.03 
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Table 1. (Continued) 
Winter    
Control  0.055 N/D 
*A1W Charlotte 0.44 0.44
† 
*A2W Charlotte 0.225 0.63
† 
*D4W Payne 0.2 0.54
† 
*E1W Payne 5.92 1.16 
*E2W Payne 0.87 0.93
‡ 
*E3W
 Payne 1.47 1.22 
*G3W Onondaga 0.04 N/D 
*G4W Onondaga 0.03 N/D 
*K3W Durand 0.11 0.65
‡ 
*K4W Durand 6.24 1.55 
B1W Charlotte 0.055 0.35
‡ 
D1W Charlotte 0.2 0.56
‡ 
L4W Durand 0.46 0.40
‡ 
N1W Durand 0.235 0.65
‡ 
N2W Durand 0.08 1.05
‡ 
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Table 2. Biodegradation of acetaminophen by isolates. The total micromoles and total 
degradation were determined at the 10-day mark. * = Initial pharmaceutical particular isolates 
were enriched on. The isolates in gray were chosen for further testing. 
Isolate  Total Micromoles 
 
Total Degradation  
 
Summer   
*F1S 455.0 + 12.6 30.9% + 0.9% 
*G1S 534.0 + 109.2 36.3% + 7.4% 
*J1S 460.9 + 128.7 31.3% + 8.8% 
*N1S 587.5 + 24.6 40.0% + 1.7% 
*O1S 466.7 + 52.1 31.7% + 3.6% 
*O2S 513.4 + 4.4 34.9% + 0.3% 
*R2S 464.2 + 31.7 31.6% + 2.2% 
*S2S 511.7 + 25.1 34.8% + 1.7% 
Fall   
*A1F 330.9 + 210.5 22.5% + 14.3% 
*A3F 421.7 + 33.6 28.7% + 2.3% 
*B1F 550.0 + 35.5 37.3% + 2.4% 
*L1F 590.0 + 56.3 40.1% + 3.9% 
*M2F 504.2 + 58.7 34.3% + 4.0% 
N3F 407.5 + 33.0 27.7% + 2.3% 
S2F 424.2 + 45.1 28.9% + 3.1% 
Winter   
*E1W 486.7 + 77.2 33.1% + 5.3% 
*E3W 481.7 + 79.1 32.8% + 5.4% 
*K4W 430.9 + 80.9 29.3% + 5.5% 
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Table 3. Growth of isolates on ibuprofen. The final absorbance and growth rate were determined 
at the 10-day mark. The final absorbance was taken at 600 nm. The growth rate represents days-1. 
Not determined (N/D) = No growth and/or immediate die-off, † = Longer than 4-day lag phase, ‡ 
= Growth, but die-off period(s), * = Initial pharmaceutical particular isolates were enriched on. 
The isolates in gray were chosen for further testing. 
Isolate Isolate Origin 
 
Final Absorbance Growth Rate 
Summer    
Control  0.005 N/D 
*H1S Onondaga 0.235 N/D 
*H2S Onondaga 0.365 0.07 
*J2S Durand 0.22 0.33 
*L1S Durand 0.35 0.17 
*P1S Payne 0.275 N/D 
*P2S Payne 0.22 0.08 
*Q1S Payne 0.39 0.10
† 
*U1S Charlotte 0.21 0.18
† 
L2S Payne 0.86 0.19 
N1S Payne 1.005 0.11 
O2S Payne 0.485 0.06 
R2S Onondaga 0.685 N/D 
S2S Charlotte 0.52 0.37 
Fall    
Control  0.005 N/D 
*B3F Charlotte 0.24 0.68 
*B4F Charlotte 0.13 0.29
† 
*C1F Charlotte 0.36 N/D 
*C2F Charlotte 0.105 0.25
‡ 
*C3F Charlotte 0.17 0.09 
*G1F Onondaga 0.32 0.58 
*G4F Onondaga 0.53 0.27 
*J1F Durand 0.42 0.14 
*J2F Durand 0.26 0.57 
*M3F Payne 0.295 0.28
‡ 
*N1F Payne 0.19 N/D 
B1F Charlotte 0.265 0.42 
L1F Payne 0.335 0.39 
M2F Payne 0.28 0.19
† 
N3F Payne 0.195 N/D 
S2F Durand 0.605 0.36 
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Table 3. (Continued) 
Winter    
Control  0.005 N/D 
*A4W Charlotte 0.14 N/D 
*B1W Charlotte 0.13 0.24 
*B2W Charlotte 0.205 0.24
‡ 
*E4W Payne 0.005 N/D 
*F2W Payne 0.14 0.9 
*H2W Onondaga 0.11 1.15 
*H3W Onondaga 0.14 N/D 
*L2W Durand 0.04 0.51
‡ 
*L3W Durand 0.1 0.19
† 
*L4W Durand 0.1 1.52 
D1W Charlotte 0.21 0.57 
E1W Payne 0.015 N/D 
E3W Payne 0.1 N/D 
N1W Durand 0.09 0.64
‡ 
N2W Durand 0.15 1.18 
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Table 4. Biodegradation of ibuprofen by isolates. The total micromoles and total degradation 
were determined at the 10-day mark. * = Initial pharmaceutical particular isolates were enriched 
on. The isolates in gray were chosen for further testing. 
Isolate  Total Micromoles 
 
Total Degradation  
 
Summer   
*J2S 357.5 + 9.5 20.4% + 0.6% 
*L1S 351.7 + 13.3 20.1% + 1.5% 
L2S 176.7 + 17.5 10.1% + 1.0% 
N1S 385.9 + 44.9 22.0% + 2.6% 
S2S 373.4 + 43.1 21.3% + 2.5% 
Fall   
*B3F 286.7 + 6.6 16.4% + 0.4% 
*G1F 353.4 + 33.3 20.2% + 1.9% 
*G4F 314.2 + 15.0 18.0% + 0.9% 
*J2F 277.5 + 14.5 15.9% + 0.8% 
B1F 266.7 + 75.5 15.2% + 4.3% 
L1F 406.7 + 99.0 23.2% + 5.7% 
S2F 334.2 + 5.0 19.1% + 0.3% 
Winter   
*B1W 409.2 + 60.7 23.4% + 3.5% 
*H2W 301.7 + 26.5 17.2% + 1.5% 
*L4W 440.0 + 49.7 25.1% + 2.9% 
D1W 330.8 + 7.7 18.9% + 0.5% 
N2W 345.9 + 18.8 19.8% + 1.1% 
 
 
 
 
 
 
 
 
 
 
40 
Table 5. Growth of isolates on naproxen. The final absorbance and growth rate were determined 
at the 10-day mark. The final absorbance was taken at 600 nm. The growth rate represents days-1. 
Not determined (N/D) = No growth and/or immediate die-off, † = Longer than 4-day lag phase, ‡ 
= Growth, but die-off period(s), * = Initial pharmaceutical particular isolates were enriched on. 
The isolates in gray were chosen for further testing. 
Isolate Isolate Origin 
 
Final Absorbance Growth Rate 
Summer    
Control  0 N/D 
*D1S Charlotte 0.535 N/D 
*D2S Charlotte 0.18 N/D 
*L2S Payne 0.9 0.17 
J2S Durand 0.027 N/D 
L1S Durand 0.325 0.21 
N1S Payne 0.61 N/D 
O2S Payne 0.44 0.05
† 
R2S Onondaga 0.495 N/D 
S2S Charlotte 0.255 N/D 
Fall    
Control  0.005 N/D 
*D4F Charlotte 0.105 N/D 
*H3F Onondaga 0.305 0.25
‡ 
*H4F Onondaga 0.535 0.07 
*K3F Durand 0.51 0.16 
*K4F Durand 0.555 0.11 
*N3F Payne 0.33 0.45 
*N4F Payne 0.15 0.23
† 
*O1F Payne 0.12 N/D 
*O2F Payne 0.28 0.72 
*O3F Payne 0.255 0.79 
*P1F Payne 0.36 0.09 
B1F Charlotte 0.275 0.25
† 
G1F Onondaga 0.26 0.58 
G4F Onondaga 0.38 0.49 
L1F Payne 0.315 0.38
† 
M2F Payne 0.37 0.13
‡ 
S2F Durand 0.475 0.17 
Winter    
Control  0.005 N/D 
*B3W Charlotte 0.01 0.27
‡ 
*B4W Charlotte 0.2 N/D 
*F4W Payne 0.17 0.08
‡ 
*F3W Payne 0.12 0.14
‡ 
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Table 5. (Continued) 
*I2W Onondaga 0.05 0.05
‡ 
*M3W Durand 0.025 N/D 
*M4W Durand 0.02 0.24
‡ 
*N1W Durand 0.19 0.16 
B1W Charlotte 0.355 0.44 
D1W Charlotte 0.075 N/D 
E1W Payne 0.03 N/D 
E3W Payne 0.16 0.32
‡ 
L4W Durand 0.33 0.49 
N2W Durand 0.145 1.09 
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Table 6. Biodegradation of naproxen by isolates. The total micromoles and total degradation 
were determined at the 10-day mark. * = Initial pharmaceutical particular isolates were enriched 
on. The isolates in gray were chosen for further testing. 
Isolate  Total Micromoles 
 
Total Degradation  
 
Summer   
*L2S 331.7 + 10.4 19.6% + 0.6% 
L1S 421.7 + 20.8 25.5% + 1.3% 
Fall   
*N3F 336.7 + 7.2 19.9% + 0.5% 
*O2F 392.5 + 79.0 23.2% + 4.7% 
*O3F 380.0 + 28.9 22.5% + 1.7% 
G1F 304.2 + 56.8 18.0% + 3.4% 
G4F 477.5 + 5.0 28.3% + 0.3% 
S2F 426.7 + 33.0 25.3% + 2.0% 
Winter   
*N1W 449.2 + 7.7 26.6% + 0.5% 
B1W 544.2 + 42.0 32.2% + 2.5% 
L4W 589.2 + 25.3 34.9% + 1.5% 
N2W 439.2 + 40.5 26.0% + 2.4% 
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Table 7. Growth of isolates on 17β-estradiol. The final absorbance and growth rate were 
determined at the 10-day mark. The final absorbance was taken at 600 nm. The growth rate 
represents days-1. Not determined (N/D) = No growth and/or immediate die-off, † = Longer than 
4-day lag phase, ‡ = Growth, but die-off period(s), * = Initial pharmaceutical particular isolates 
were enriched on. The isolates in gray were chosen for further testing. 
Isolate Isolate Origin 
 
Final Absorbance Growth Rate 
Fall    
Control  0.075 N/D 
*P2F Charlotte 0.22 0.22
† 
*Q1F Charlotte 0.3 0.17
‡ 
*Q2F Onondaga 0.335 0.06 
*R1F Payne 0.075 N/D 
*R2F Payne 0.22 N/D 
*S1F Payne 0.105 0.08 
*S2F Durand 0.765 0.32 
*T1F Durand 0.26 N/D 
*T2F Durand 0.28 0.38 
*U1F Durand 0.345 0.21 
B1F Charlotte 0.28 0.38 
G1F Onondaga 0.29 0.51
‡ 
G4F Onondaga 0.12 0.28
‡ 
L1F Payne 0.355 0.40 
M2F Payne 0.295 0.24 
N3F Payne 0.075 0.25
† 
Winter    
Control  0.075 N/D 
*D1W Charlotte 0.3 0.33 
*D2W Charlotte 0.25 0.05 
*G1W Payne 0.2 N/D 
*G2W Payne 0.32 N/D 
*J3W Onondaga 0.1 0.10
‡ 
*N2W Durand 0.35 0.24 
*N3W Durand 0.51 0.12
‡ 
*O1W Durand 0.01 N/D 
B1W Charlotte 0.335 0.27 
E1W Payne 0.255 0.38 
E3W Payne 0.22 0.44
‡ 
L4W Durand 0.35 0.45 
N1W Durand 0.18 0.35
‡ 
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Table 8. Biodegradation of 17β-estradiol by isolates. The total micromoles and total degradation 
were determined at the 10-day mark. * = Initial pharmaceutical particular isolates were enriched 
on. The isolates in gray were chosen for further testing. 
Isolate  Total Micromoles  
 
Total Degradation  
 
Fall   
*S2F 435.0 + 33.1 23.7% + 1.8% 
*T2F 469.2 + 134.0 25.6% + 7.3% 
*U1F 425.0 + 7.5 23.2% + 0.4% 
B1F 400.9 + 38.3 21.8% + 2.1% 
L1F 341.7 + 96.3 18.6% + 5.3% 
M2F 292.5 + 85.3 15.9% + 4.7% 
Winter   
*D1W 450.0 + 50.2 24.5% + 2.8% 
*N2W 496.7 + 51.3 27.1% + 2.8% 
B1W 534.2 + 34.7 29.1% + 1.9% 
E1W 501.7 + 38.9 27.3% + 2.1% 
L4W 535.9 + 43.1 29.2% + 2.4% 
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Table 9. Growth of high capacity isolates on contaminants in natural water sources. The final 
absorbance and growth rate were determined at the 10-day mark. The final absorbance was taken 
at 600 nm. The growth rate represents days-1. Not determined (N/D) = No growth and/or 
immediate die-off, † = Longer than 4-day lag phase, ‡ = Growth, but die-off period(s). The 
isolates in gray were chosen for further testing. 
Isolate & Source on Waters Final Absorbance Growth Rate 
 
L1S   
L1S Durand 0.15 0.07
‡ 
Durand Ibuprofen 0.009 N/D 
L1S Durand Ibuprofen 0.06 N/D 
Durand Naproxen 0.002 0.13† 
L1S Durand Naproxen 0.22 0.09 
N1S   
N1S Payne 0.1 0.11† 
Payne Acetaminophen 1.61 0.78† 
N1S Payne Acetaminophen 1.48 0.78 
Payne Ibuprofen 0.085 1.04‡ 
N1S Payne Ibuprofen 0.04 N/D 
S2S   
S2S Charlotte 0.09 0.17
‡ 
Charlotte Acetaminophen 1.25 0.45† 
S2S Charlotte Acetaminophen 0.98 0.46 
Charlotte Ibuprofen 0.05 N/D 
S2S Charlotte Ibuprofen 0.26 0.15 
B1F   
B1F Charlotte 0.03 N/D 
Charlotte Acetaminophen 3.65 0.99 
B1F Charlotte Acetaminophen 5.255 1.23 
Charlotte 17β-Estradiol 0.08 N/D 
B1F Charlotte 17β-Estradiol 0.05 N/D 
G4F   
G4F Onondaga 0.03 N/D 
Onondaga Ibuprofen 0.02 1.02‡ 
G4F Onondaga Ibuprofen 0.075 0.12
‡ 
Onondaga Naproxen 0.06 N/D 
G4F Onondaga Naproxen 0.05 N/D 
N3F   
N3F Payne 0.02 N/D 
Payne Acetaminophen 0.085 0.61† 
N3F Payne Acetaminophen 3.725 0.82 
Payne Naproxen 0.03 N/D 
N3F Payne Naproxen 0.13 N/D 
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Table 9. (Continued) 
S2F   
S2F Durand 0.005 N/D 
Durand Acetaminophen 1.865 0.46† 
S2F Durand Acetaminophen 3.295 1.80 
Durand Ibuprofen 0.025 N/D 
S2F Durand Ibuprofen 0.14 0.28 
Durand Naproxen 0.025 N/D 
S2F Durand Naproxen 0.02 N/D 
Durand 17β-Estradiol 0.055 N/D 
S2F Durand 17β-Estradiol 0.015 N/D 
B1W   
B1W Charlotte 0.025 N/D 
Charlotte Ibuprofen 0.035 0.46 
B1W Charlotte Ibuprofen 0.035 0.12
‡ 
Charlotte Naproxen 0.16 0.03 
B1W Charlotte Naproxen 0.235 0.06 
Charlotte 17β-Estradiol 0.08 N/D 
B1W Charlotte 17β-Estradiol 0.09 0.16‡ 
D1W   
D1W Charlotte 0.03 N/D 
Charlotte Ibuprofen 0.035 0.46 
D1W Charlotte Ibuprofen 0.075 N/D 
Charlotte 17β-Estradiol 0.08 N/D 
D1W Charlotte 17β-Estradiol 0.055 0.13‡ 
E1W   
E1W Payne 0.03 N/D 
Payne Acetaminophen 0.085 N/D 
E1W Payne Acetaminophen 1.595 0.80 
Payne 17β-Estradiol 0.06 N/D 
E1W Payne 17β-Estradiol 0.07 N/D 
L4W   
L4W Durand 0.03 N/D 
Durand Ibuprofen 0.025 N/D 
L4W Durand Ibuprofen 0.095 N/D 
Durand Naproxen 0.025 N/D 
L4W Durand Naproxen 0.035 N/D 
Durand 17β-Estradiol 0.055 N/D 
L4W Durand 17β-Estradiol 0.025 N/D 
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Table 9. (Continued) 
N2W   
N2W Durand 0.03 N/D 
Durand Ibuprofen 0.025 0.08‡ 
N2W Durand Ibuprofen 0.13 0.05 
Durand Naproxen 0.025 N/D 
N2W Durand Naproxen 0.16 0.10 
Durand 17β-Estradiol 0.055 N/D 
N2W Durand 17β-Estradiol 0.055 N/D 
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Table 10. One-way ANOVA comparing the biodegradation of pharmaceuticals by isolates in 
natural water (p < 0.05). Significant isolates are highlighted in gray. 
Isolate Source Site P-value F-value Total df 
N1S Acetaminophen Payne 0.152 3.77 8 
S2S Acetaminophen Charlotte 0.736 0.34 8 
N3F Acetaminophen Payne 0.384 1.34 8 
B1F Acetaminophen Charlotte 0.506 0.86 8 
S2F Acetaminophen Durand 0.274 2.05 8 
E1W Acetaminophen Payne 0.019 19.53 8 
S2S Ibuprofen Charlotte 0.680 0.44 8 
S2F Ibuprofen Durand 0.587 0.64 8 
N2W Ibuprofen Durand 0.034 12.67 8 
L1S Naproxen Durand 0.315 1.74 8 
B1W Naproxen Charlotte 0.032 13.53 8 
N2W Naproxen Durand 0.165 3.48 8 
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Table 11. Characteristics of isolates from the summer, fall, and winter cultures.  
Isolate Pigment Gram Characteristics 
Summer   
C1S Pale yellow Negative rods 
F1S Orange Negative rods 
G1S Pale Yellow Negative rods  
J1S Off-white Positive rods 
J2S Red Negative rods 
L1S Off-white Positive rods 
L2S Fluorescent  Positive cocci 
 N1S  Yellow Positive cocci 
O1S Orange Negative rods 
O2S White Negative rods 
R2S Off-white Positive rods 
S2S Pale Orange Positive cocci 
Fall   
A1F White Positive rods 
A3F Orange Positive cocci 
B1F Yellow Negative rods 
B3F White Negative rods 
G1F` Off-white Negative rods 
G4F White Positive rods 
J2F Off-white Negative rods 
L1F Off-white Negative rods 
M2F White Negative rods 
N3F Pale Orange Negative rods 
O2F Bright Orange Positive rods 
O3F Mustard Yellow Negative cocci 
S2F Yellow Negative rods 
T2F White Negative rods 
U1F Pink Negative rods 
Winter   
B1W Off-white Negative rods 
D1W Pale Orange Positive cocci 
E1W White Negative rods 
E3W Pale yellow Positive rods 
F2W White Negative cocci 
H2W Pale yellow Negative rods 
K4W White Negative cocci 
L4W Off-White Negative rods 
N1W White Positive rods 
N2W Orange Negative rods 
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Figures 
 
 
Figure 1a. Structure of ibuprofen. 
 
 
Figure 1b. Structure of naproxen. 
 
 
 
Figure 1c. Structure of acetaminophen. 
 
 
 
Figure 1d. Structure of 17β-estradiol. 
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Figure 2. Google Earth image of Onondaga Lake. The red placemark with the S signifies the sampling location. The 
red placemark with the star signifies the Metropolitan Syracuse WWTP. 
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Figure 3a. Google Earth image of the Lake Ontario sampling sites. The red placemarks signify the sampling 
locations of each beach. 
 
 
Figure 3b. Google Earth image of Payne Beach. The red placemark with the S signifies the sampling location. The 
red placemark with the star signifies the Northwest Quadrant Treatment Plant. 
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Figure 3c. Google Earth image of Charlotte Beach. The red placemark with the S signifies the sampling location. 
The water being discharged into the lake is from the Genesee River. 
 
 
 
Figure 3d. Google Earth image of Durand Beach. The red placemark with the S signifies the sampling location. The 
red placemark with the star signifies the Van Lare WWTP. 
54 
Figure 4. Enrichment technique after 1 week of growth in culturing flasks. Weeks 2, 3, and 4 all following the same 
general protocol except that 4 mL of solution are taken out of each flask. Water/sediment from the stock bottle is not 
added after initial enrichment.  
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Figure 5. Biometer flask setup. Bushnell-Haas medium, isolate of choice, and selected pharmaceutical are placed in 
the base. KOH is placed in the sidearm and ascarite is placed in the top; a) side view, and b) front view.  
 
a b 
56 
 
Figure 6. Growth of isolates on acetaminophen. N1-S (summer), L1-F (fall), E1-W (winter). 
 
    
Figure 7. a) Control, b) N1S, c) L1F, and d) E1W after 10 days of growth on acetaminophen. 
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Figure 8. Degradation of acetaminophen by isolates. Standard error bars are representative of each isolate’s three 
trials. N1-S (summer), L1-F (fall), E1-W (winter). 
 
   
Figure 9. a) N1S after 0 days, b) 4 days, and c) 10 days of growth on acetaminophen. 
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Figure 11. Degradation of naproxen by isolate L1S in Durand Beach water. Standard error bars are representative of 
each of the three trials. L1-S Durand represents the isolate in Durand Beach water solely, Naproxen Durand 
represents naproxen in Durand Beach water solely, and L1-S Naproxen Durand represents the isolate in Durand 
Beach water with naproxen.  
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Figure 12. Gram stains of two different isolates; a) N1S and b) B1F. 
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Appendix  
 
Supplemental Tables 
 
Table S-1a. Monthly precipitation rates for the Rochester region (data from (Weather 
Underground, 2016a)). Precipitation was measured from the Greater Rochester International 
Airport. 
Region Monthly Precipitation 
 May 2015 September 2015 March 2016 August 2016 
Rochester 4.2 cm 4.0 cm 0.97 cm 
(snow depth: 2.54 cm) 
2.8 cm 
 
Table S-1b. Monthly precipitation rates for the Syracuse region (data from Weather 
Underground, 2016b)). Precipitation was measured from the Syracuse Hancock International 
Airport. 
Region Monthly Precipitation 
 June 2015 September 2015 February 2016 August 2016 
Syracuse 6.7 cm 4.8 cm 5.0 cm 
(snow depth: 30.5 cm) 
2.8 cm 
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Table S-2. Environmental measurements of the surface water samples taken on August 15, 2016.  
Surface Water Temperature (°C) pH Phosphate (mg/L) Nitrate (mg/L) 
Onondaga 27 8.61 0.24 2.2 
Charlotte 26 8.61 0.14 2.2 
Payne 25 8.25 0.13 1.32 
Durand 25 8.32 0.07 0.44 
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Table S-3a. Average CFU/mL of colonies from each sampling site growing on the selected 
pharmaceuticals at week 4, day 7. The average was determined from the summer, fall, and winter 
enrichments. A one-way ANOVA and a post-hoc Tukey HSD test were performed on the data (p 
< 0.05). “b” indicates a significant mean from “a”, * = Indicates use of Fisher LSD test. The 
results of the ANOVA test are listed in Table S-3b. 
Sample Plates Average cfu/mL 
Acetaminophen  
Durand Beachb 1.3x108 
Payne Beacha 4.7x106 
Charlotte Beachab 2.1x107 
Onondaga Lakea 7.8x106 
*Ibuprofen  
Durand Beachb 6.1x107 
Payne Beacha 1.3x106 
Charlotte Beachab 2.0x107 
Onondaga Lakea 4.4x106 
Naproxen  
Durand Beacha 5.2x107 
Payne Beacha 5.2x107 
Charlotte Beacha 4.9x106 
Onondaga Lakea 1.9x106 
17β-Estradiol  
Durand Beacha 1.1x108 
Payne Beacha 2.5x107 
Charlotte Beacha 2.3x107 
Onondaga Lakea 3.5x106 
 
Table S-3b. One-way ANOVA comparing the CFU/mL of colonies growing on the selected 
pharmaceuticals versus the sampling sites (p < 0.05). Week 4, day 7 data (without averaging) 
was considered for all calculations. Significant isolates are highlighted in gray. 
CFU/mL of Colonies Versus Sampling Site 
Pharmaceutical P-value F-value Total df 
Acetaminophen 0.021 5.80 11 
Ibuprofen 0.046 4.22 11 
Naproxen 0.426 1.04 11 
17β-Estradiol 0.316 1.63 11 
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Table S-4a. Average diversity of colonies from each sampling site growing on the selected 
pharmaceuticals at week 4, day 7. The average diversity was determined from the summer, fall, 
and winter enrichments. A one-way ANOVA and a post-hoc Tukey test were performed on the 
data (p < 0.05). “a” indicates no significant difference in the mean. The results of the ANOVA 
test are listed in Table S-4b. 
Sample Plates Number of Different Colonies 
Acetaminophen  
Durand Beacha 4.3 
Payne Beacha 4.7 
Charlotte Beacha 4.7 
Onondaga Lakea 5.3 
Ibuprofen  
Durand Beacha 4.7 
Payne Beacha 5.3 
Charlotte Beacha 4.7 
Onondaga Lakea 5.3 
Naproxen  
Durand Beacha 4.3 
Payne Beacha 5.3 
Charlotte Beacha 4.7 
Onondaga Lakea 6.0 
17β-Estradiol  
Durand Beacha 5.0 
Payne Beacha 4.5 
Charlotte Beacha 5.5 
Onondaga Lakea 4.5 
 
Table S-4b. One-way ANOVA comparing the diversity of colonies growing on the selected 
pharmaceuticals versus the sampling sites (p < 0.05). Week 4, day 7 data (without averaging) 
was considered for all calculations.  
Diversity of Colonies Versus Sampling Site 
Pharmaceutical P-value F-value Total df 
Acetaminophen 0.760 0.40 11 
Ibuprofen 0.750 0.41 11 
Naproxen 0.168 2.19 11 
17β-Estradiol 0.689 0.52 11 
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Supplemental Figures  
 
  
Figure S-1. 500 mL graduated water dipper; a) 60-ft long dipper, b) 500 mL cup. 
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Figure S-2a. Gram stains of a) J1S, b) L1S, c) L2S, and d) R2S. 
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Figure S-2b. Gram stains of a) L1F, b) M2F, c) O2F, and d) S2F. 
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Figure S-2c. Gram stains of a) H2W and b) N2W. 
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